Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
Junko Terada-Hirashima
1
, MPH, MD ;
Manabu Suzuki
1
, MD ;
Yukari Uemura
2
, PhD ;
Masayuki Hojo
1
, MD, PhD ;
Ayako Mikami
2
, MD, PhD ;
Wataru Sugiura
2
, MD, PhD ;
Norio Ohmagari
3
, MD, PhD ;
Haruhito Sugiyama
1
, MD, PhD
1
Department of Pulmonary Medicine, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan
2
Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
3
Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan
Corresponding Author:
-
Junko Terada-Hirashima, MPH, MD
-
Department of Pulmonary Medicine
-
Center Hospital of the National Center for Global Health and Medicine
-
1-21-1 Toyama Shinjuku-ku
-
Tokyo
-
Japan
-
Phone:
81 332027181
-
Email: jterada@hosp.ncgm.go.jp